US Kidney Research Corp Invited to Speak at American Society for Artificial Internal Organs Conference
USKRC will present implantable artificial kidney technology to researchers and scientists
Roseville, CA (PRUnderground) March 6th, 2020
US Kidney Research Corporation (USKRC) received a personal invitation from the International Federation for Artificial Organs to speak at the American Society for Artificial Internal Organs (ASAIO) conference in Chicago to be held in June, 2020. This “special session” at this year’s meeting of ASAIO is entitled “Implantable Artificial Kidneys: Current status and Challenges.” Dr. Jamie Hestekin, the head of research at the University of Arkansas and research/scientist partner for USKRC will attend and give the presentation.
USKRC will be presenting their novel dialysate free blood purifying technology to leading researchers and scientists involved in pursuing research which could make the implantable artificial kidney a reality in the future.
Roland G. Ludlow, Founder/CEO for USKRC said, “The International Federation for Artificial Organs is a prestigious organization with worldwide recognition. We are honored by the invitation and pleased for the opportunity to present our novel technology at this year’s ASAIO conference”.
The mission of the International Federation of Artificial Organs is to increase and encourage knowledge and research on artificial organs, apheresis, tissue engineering, regenerative medicine and other related topics, to facilitate the international exchange of knowledge, and to provide education related to the improvement and optimal utilization of organ assist devices.
The Federation arranges biennial congresses jointly with the Member Societies with special emphasis on international aspects and dissemination of knowledge into developing countries. The international peer reviewed journal ARTIFICIAL ORGANS is the “Official Journal of The Federation.”
About US Kidney Research Corporation
US Kidney Research Corporation (USKRC): US Kidney Research Corporation (formerly Curion Research Corporation), is a Delaware C-Corp founded in June, 2015. For over 4 years, US Kidney Research Corporation has been involved in R&D of the world’s first waterless renal replacement technology. Unlike standard dialysis, their new technology does not require purified water, dialysate concentrate solutions, or a dialyzer.
They are the first in the world to create synthetic urine (urine produced synthetically from an artificial device) during animal studies using their new blood purifying technology that involves filtration and ion transport processes similar to the native kidney.
They are an award winner of KidneyX Redesign Dialysis contest sponsored in partnership by US Dept. of Health and Human Services and the American Society of Nephrology.